Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Hepatitis C Treatment Market Growth (Status and Outlook) 2022-2028

  • LP 4871601
  • 87 Pages
  • February 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Hepatitis C Treatment will have significant change from previous year. According to our (LP Information) latest study, the global Hepatitis C Treatment market size is USD million in 2022 from USD 41800 million in 2021, with a change of % between 2021 and 2022. The global Hepatitis C Treatment market size will reach USD 84730 million in 2028, growing at a CAGR of 10.6% over the analysis period.

The United States Hepatitis C Treatment market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Hepatitis C Treatment market, reaching US$ million by the year 2028. As for the Europe Hepatitis C Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Hepatitis C Treatment players cover AbbVie, Gilead, Kenilworth, and Merck, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Hepatitis C Treatment market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

Rx

OTC

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Hospital

Clinic

Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

AbbVie

Gilead

Kenilworth

Merck

Johnson & Johnson

Bristol-Myers Squibb

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Hepatitis C Treatment Market Size 2017-2028

2.1.2 Hepatitis C Treatment Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Hepatitis C Treatment Segment by Type

2.2.1 Rx

2.2.2 OTC

2.3 Hepatitis C Treatment Market Size by Type

2.3.1 Hepatitis C Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Hepatitis C Treatment Market Size Market Share by Type (2017-2022)

2.4 Hepatitis C Treatment Segment by Application

2.4.1 Hospital

2.4.2 Clinic

2.4.3 Other

2.5 Hepatitis C Treatment Market Size by Application

2.5.1 Hepatitis C Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Hepatitis C Treatment Market Size Market Share by Application (2017-2022)

3 Hepatitis C Treatment Market Size by Player

3.1 Hepatitis C Treatment Market Size Market Share by Players

3.1.1 Global Hepatitis C Treatment Revenue by Players (2020-2022)

3.1.2 Global Hepatitis C Treatment Revenue Market Share by Players (2020-2022)

3.2 Global Hepatitis C Treatment Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Hepatitis C Treatment by Regions

4.1 Hepatitis C Treatment Market Size by Regions (2017-2022)

4.2 Americas Hepatitis C Treatment Market Size Growth (2017-2022)

4.3 APAC Hepatitis C Treatment Market Size Growth (2017-2022)

4.4 Europe Hepatitis C Treatment Market Size Growth (2017-2022)

4.5 Middle East & Africa Hepatitis C Treatment Market Size Growth (2017-2022)

5 Americas

5.1 Americas Hepatitis C Treatment Market Size by Country (2017-2022)

5.2 Americas Hepatitis C Treatment Market Size by Type (2017-2022)

5.3 Americas Hepatitis C Treatment Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Hepatitis C Treatment Market Size by Region (2017-2022)

6.2 APAC Hepatitis C Treatment Market Size by Type (2017-2022)

6.3 APAC Hepatitis C Treatment Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Hepatitis C Treatment by Country (2017-2022)

7.2 Europe Hepatitis C Treatment Market Size by Type (2017-2022)

7.3 Europe Hepatitis C Treatment Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Hepatitis C Treatment by Region (2017-2022)

8.2 Middle East & Africa Hepatitis C Treatment Market Size by Type (2017-2022)

8.3 Middle East & Africa Hepatitis C Treatment Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Hepatitis C Treatment Market Forecast

10.1 Global Hepatitis C Treatment Forecast by Regions (2023-2028)

10.1.1 Global Hepatitis C Treatment Forecast by Regions (2023-2028)

10.1.2 Americas Hepatitis C Treatment Forecast

10.1.3 APAC Hepatitis C Treatment Forecast

10.1.4 Europe Hepatitis C Treatment Forecast

10.1.5 Middle East & Africa Hepatitis C Treatment Forecast

10.2 Americas Hepatitis C Treatment Forecast by Country (2023-2028)

10.2.1 United States Hepatitis C Treatment Market Forecast

10.2.2 Canada Hepatitis C Treatment Market Forecast

10.2.3 Mexico Hepatitis C Treatment Market Forecast

10.2.4 Brazil Hepatitis C Treatment Market Forecast

10.3 APAC Hepatitis C Treatment Forecast by Region (2023-2028)

10.3.1 China Hepatitis C Treatment Market Forecast

10.3.2 Japan Hepatitis C Treatment Market Forecast

10.3.3 Korea Hepatitis C Treatment Market Forecast

10.3.4 Southeast Asia Hepatitis C Treatment Market Forecast

10.3.5 India Hepatitis C Treatment Market Forecast

10.3.6 Australia Hepatitis C Treatment Market Forecast

10.4 Europe Hepatitis C Treatment Forecast by Country (2023-2028)

10.4.1 Germany Hepatitis C Treatment Market Forecast

10.4.2 France Hepatitis C Treatment Market Forecast

10.4.3 UK Hepatitis C Treatment Market Forecast

10.4.4 Italy Hepatitis C Treatment Market Forecast

10.4.5 Russia Hepatitis C Treatment Market Forecast

10.5 Middle East & Africa Hepatitis C Treatment Forecast by Region (2023-2028)

10.5.1 Egypt Hepatitis C Treatment Market Forecast

10.5.2 South Africa Hepatitis C Treatment Market Forecast

10.5.3 Israel Hepatitis C Treatment Market Forecast

10.5.4 Turkey Hepatitis C Treatment Market Forecast

10.5.5 GCC Countries Hepatitis C Treatment Market Forecast

10.6 Global Hepatitis C Treatment Forecast by Type (2023-2028)

10.7 Global Hepatitis C Treatment Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 AbbVie

11.1.1 AbbVie Company Information

11.1.2 AbbVie Hepatitis C Treatment Product Offered

11.1.3 AbbVie Hepatitis C Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 AbbVie Main Business Overview

11.1.5 AbbVie Latest Developments

11.2 Gilead

11.2.1 Gilead Company Information

11.2.2 Gilead Hepatitis C Treatment Product Offered

11.2.3 Gilead Hepatitis C Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Gilead Main Business Overview

11.2.5 Gilead Latest Developments

11.3 Kenilworth

11.3.1 Kenilworth Company Information

11.3.2 Kenilworth Hepatitis C Treatment Product Offered

11.3.3 Kenilworth Hepatitis C Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Kenilworth Main Business Overview

11.3.5 Kenilworth Latest Developments

11.4 Merck

11.4.1 Merck Company Information

11.4.2 Merck Hepatitis C Treatment Product Offered

11.4.3 Merck Hepatitis C Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Merck Main Business Overview

11.4.5 Merck Latest Developments

11.5 Johnson & Johnson

11.5.1 Johnson & Johnson Company Information

11.5.2 Johnson & Johnson Hepatitis C Treatment Product Offered

11.5.3 Johnson & Johnson Hepatitis C Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Johnson & Johnson Main Business Overview

11.5.5 Johnson & Johnson Latest Developments

11.6 Bristol-Myers Squibb

11.6.1 Bristol-Myers Squibb Company Information

11.6.2 Bristol-Myers Squibb Hepatitis C Treatment Product Offered

11.6.3 Bristol-Myers Squibb Hepatitis C Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Bristol-Myers Squibb Main Business Overview

11.6.5 Bristol-Myers Squibb Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Hepatitis C Treatment Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Rx

Table 3. Major Players of OTC

Table 4. Hepatitis C Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 5. Global Hepatitis C Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 6. Global Hepatitis C Treatment Market Size Market Share by Type (2017-2022)

Table 7. Hepatitis C Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Hepatitis C Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 9. Global Hepatitis C Treatment Market Size Market Share by Application (2017-2022)

Table 10. Global Hepatitis C Treatment Revenue by Players (2020-2022) & ($ Millions)

Table 11. Global Hepatitis C Treatment Revenue Market Share by Player (2020-2022)

Table 12. Hepatitis C Treatment Key Players Head office and Products Offered

Table 13. Hepatitis C Treatment Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 14. New Products and Potential Entrants

Table 15. Mergers & Acquisitions, Expansion

Table 16. Global Hepatitis C Treatment Market Size by Regions 2017-2022 & ($ Millions)

Table 17. Global Hepatitis C Treatment Market Size Market Share by Regions (2017-2022)

Table 18. Americas Hepatitis C Treatment Market Size by Country (2017-2022) & ($ Millions)

Table 19. Americas Hepatitis C Treatment Market Size Market Share by Country (2017-2022)

Table 20. Americas Hepatitis C Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 21. Americas Hepatitis C Treatment Market Size Market Share by Type (2017-2022)

Table 22. Americas Hepatitis C Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 23. Americas Hepatitis C Treatment Market Size Market Share by Application (2017-2022)

Table 24. APAC Hepatitis C Treatment Market Size by Region (2017-2022) & ($ Millions)

Table 25. APAC Hepatitis C Treatment Market Size Market Share by Region (2017-2022)

Table 26. APAC Hepatitis C Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 27. APAC Hepatitis C Treatment Market Size Market Share by Type (2017-2022)

Table 28. APAC Hepatitis C Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 29. APAC Hepatitis C Treatment Market Size Market Share by Application (2017-2022)

Table 30. Europe Hepatitis C Treatment Market Size by Country (2017-2022) & ($ Millions)

Table 31. Europe Hepatitis C Treatment Market Size Market Share by Country (2017-2022)

Table 32. Europe Hepatitis C Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 33. Europe Hepatitis C Treatment Market Size Market Share by Type (2017-2022)

Table 34. Europe Hepatitis C Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 35. Europe Hepatitis C Treatment Market Size Market Share by Application (2017-2022)

Table 36. Middle East & Africa Hepatitis C Treatment Market Size by Region (2017-2022) & ($ Millions)

Table 37. Middle East & Africa Hepatitis C Treatment Market Size Market Share by Region (2017-2022)

Table 38. Middle East & Africa Hepatitis C Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Hepatitis C Treatment Market Size Market Share by Type (2017-2022)

Table 40. Middle East & Africa Hepatitis C Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Hepatitis C Treatment Market Size Market Share by Application (2017-2022)

Table 42. Key Market Drivers & Growth Opportunities of Hepatitis C Treatment

Table 43. Key Market Challenges & Risks of Hepatitis C Treatment

Table 44. Key Industry Trends of Hepatitis C Treatment

Table 45. Global Hepatitis C Treatment Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 46. Global Hepatitis C Treatment Market Size Market Share Forecast by Regions (2023-2028)

Table 47. Global Hepatitis C Treatment Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 48. Global Hepatitis C Treatment Market Size Market Share Forecast by Type (2023-2028)

Table 49. Global Hepatitis C Treatment Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 50. Global Hepatitis C Treatment Market Size Market Share Forecast by Application (2023-2028)

Table 51. AbbVie Details, Company Type, Hepatitis C Treatment Area Served and Its Competitors

Table 52. AbbVie Hepatitis C Treatment Product Offered

Table 53. AbbVie Hepatitis C Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 54. AbbVie Main Business

Table 55. AbbVie Latest Developments

Table 56. Gilead Details, Company Type, Hepatitis C Treatment Area Served and Its Competitors

Table 57. Gilead Hepatitis C Treatment Product Offered

Table 58. Gilead Main Business

Table 59. Gilead Hepatitis C Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 60. Gilead Latest Developments

Table 61. Kenilworth Details, Company Type, Hepatitis C Treatment Area Served and Its Competitors

Table 62. Kenilworth Hepatitis C Treatment Product Offered

Table 63. Kenilworth Main Business

Table 64. Kenilworth Hepatitis C Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 65. Kenilworth Latest Developments

Table 66. Merck Details, Company Type, Hepatitis C Treatment Area Served and Its Competitors

Table 67. Merck Hepatitis C Treatment Product Offered

Table 68. Merck Main Business

Table 69. Merck Hepatitis C Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 70. Merck Latest Developments

Table 71. Johnson & Johnson Details, Company Type, Hepatitis C Treatment Area Served and Its Competitors

Table 72. Johnson & Johnson Hepatitis C Treatment Product Offered

Table 73. Johnson & Johnson Main Business

Table 74. Johnson & Johnson Hepatitis C Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 75. Johnson & Johnson Latest Developments

Table 76. Bristol-Myers Squibb Details, Company Type, Hepatitis C Treatment Area Served and Its Competitors

Table 77. Bristol-Myers Squibb Hepatitis C Treatment Product Offered

Table 78. Bristol-Myers Squibb Main Business

Table 79. Bristol-Myers Squibb Hepatitis C Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 80. Bristol-Myers Squibb Latest Developments

List of Figures

Figure 1. Hepatitis C Treatment Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Hepatitis C Treatment Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Hepatitis C Treatment Market Size Market Share by Type in 2021

Figure 7. Hepatitis C Treatment in Hospital

Figure 8. Global Hepatitis C Treatment Market: Hospital (2017-2022) & ($ Millions)

Figure 9. Hepatitis C Treatment in Clinic

Figure 10. Global Hepatitis C Treatment Market: Clinic (2017-2022) & ($ Millions)

Figure 11. Hepatitis C Treatment in Other

Figure 12. Global Hepatitis C Treatment Market: Other (2017-2022) & ($ Millions)

Figure 13. Global Hepatitis C Treatment Market Size Market Share by Application in 2021

Figure 14. Global Hepatitis C Treatment Revenue Market Share by Player in 2021

Figure 15. Global Hepatitis C Treatment Market Size Market Share by Regions (2017-2022)

Figure 16. Americas Hepatitis C Treatment Market Size 2017-2022 ($ Millions)

Figure 17. APAC Hepatitis C Treatment Market Size 2017-2022 ($ Millions)

Figure 18. Europe Hepatitis C Treatment Market Size 2017-2022 ($ Millions)

Figure 19. Middle East & Africa Hepatitis C Treatment Market Size 2017-2022 ($ Millions)

Figure 20. Americas Hepatitis C Treatment Value Market Share by Country in 2021

Figure 21. Americas Hepatitis C Treatment Consumption Market Share by Type in 2021

Figure 22. Americas Hepatitis C Treatment Market Size Market Share by Application in 2021

Figure 23. United States Hepatitis C Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 24. Canada Hepatitis C Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 25. Mexico Hepatitis C Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 26. Brazil Hepatitis C Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 27. APAC Hepatitis C Treatment Market Size Market Share by Region in 2021

Figure 28. APAC Hepatitis C Treatment Market Size Market Share by Application in 2021

Figure 29. China Hepatitis C Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 30. Japan Hepatitis C Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 31. Korea Hepatitis C Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 32. Southeast Asia Hepatitis C Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 33. India Hepatitis C Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 34. Australia Hepatitis C Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 35. Europe Hepatitis C Treatment Market Size Market Share by Country in 2021

Figure 36. Europe Hepatitis C Treatment Market Size Market Share by Type in 2021

Figure 37. Europe Hepatitis C Treatment Market Size Market Share by Application in 2021

Figure 38. Germany Hepatitis C Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 39. France Hepatitis C Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 40. UK Hepatitis C Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 41. Italy Hepatitis C Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 42. Russia Hepatitis C Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 43. Middle East & Africa Hepatitis C Treatment Market Size Market Share by Region in 2021

Figure 44. Middle East & Africa Hepatitis C Treatment Market Size Market Share by Type in 2021

Figure 45. Middle East & Africa Hepatitis C Treatment Market Size Market Share by Application in 2021

Figure 46. Egypt Hepatitis C Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 47. South Africa Hepatitis C Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 48. Israel Hepatitis C Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 49. Turkey Hepatitis C Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 50. GCC Country Hepatitis C Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 51. Americas Hepatitis C Treatment Market Size 2023-2028 ($ Millions)

Figure 52. APAC Hepatitis C Treatment Market Size 2023-2028 ($ Millions)

Figure 53. Europe Hepatitis C Treatment Market Size 2023-2028 ($ Millions)

Figure 54. Middle East & Africa Hepatitis C Treatment Market Size 2023-2028 ($ Millions)

Figure 55. United States Hepatitis C Treatment Market Size 2023-2028 ($ Millions)

Figure 56. Canada Hepatitis C Treatment Market Size 2023-2028 ($ Millions)

Figure 57. Mexico Hepatitis C Treatment Market Size 2023-2028 ($ Millions)

Figure 58. Brazil Hepatitis C Treatment Market Size 2023-2028 ($ Millions)

Figure 59. China Hepatitis C Treatment Market Size 2023-2028 ($ Millions)

Figure 60. Japan Hepatitis C Treatment Market Size 2023-2028 ($ Millions)

Figure 61. Korea Hepatitis C Treatment Market Size 2023-2028 ($ Millions)

Figure 62. Southeast Asia Hepatitis C Treatment Market Size 2023-2028 ($ Millions)

Figure 63. India Hepatitis C Treatment Market Size 2023-2028 ($ Millions)

Figure 64. Australia Hepatitis C Treatment Market Size 2023-2028 ($ Millions)

Figure 65. Germany Hepatitis C Treatment Market Size 2023-2028 ($ Millions)

Figure 66. France Hepatitis C Treatment Market Size 2023-2028 ($ Millions)

Figure 67. UK Hepatitis C Treatment Market Size 2023-2028 ($ Millions)

Figure 68. Italy Hepatitis C Treatment Market Size 2023-2028 ($ Millions)

Figure 69. Russia Hepatitis C Treatment Market Size 2023-2028 ($ Millions)

Figure 70. Spain Hepatitis C Treatment Market Size 2023-2028 ($ Millions)

Figure 71. Egypt Hepatitis C Treatment Market Size 2023-2028 ($ Millions)

Figure 72. South Africa Hepatitis C Treatment Market Size 2023-2028 ($ Millions)

Figure 73. Israel Hepatitis C Treatment Market Size 2023-2028 ($ Millions)

Figure 74. Turkey Hepatitis C Treatment Market Size 2023-2028 ($ Millions)

Figure 75. GCC Countries Hepatitis C Treatment Market Size 2023-2028 ($ Millions)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390